Cardiovascular effect of preeclampsia upon offspring development: Are (Pro) renin-renin receptor ((P)RR) and gender related?

Document Type : Original Article


1 Laboratorio de Farmacología Molecular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Casco de Sto. Tomás, Ciudad de México, México

2 Laboratorio de Biología Molecular, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina del Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Casco de Sto. Tomás, Ciudad de México, México


Objective(s): Preeclampsia (PE) is a complication of pregnancy that might increase progeny risk of cardiovascular and metabolic problems, mainly in males. Renin angiotensin aldosterone system is known to be involved. (Pro) renin/renin receptor ((P)RR) has been shown to participate in cardiovascular pathology. The aim of this work was to evaluate (P)RR expression and function upon cardiovascular and renal tissues from PE dams’ offspring.
Materials and Methods: We used offspring from normal pregnant and preeclamptic rats, evaluating body, heart, aorta and kidney weight, length, and blood pressure along 3 months after birth. Subsets of animals received handle region peptide (HRP) (0.2 mg/Kg, sc). Another group received vehicle. Animals were sacrificed at first, second, and third months of age, tissues were extracted and processed for immunoblot to detect (P)RR, PLZF, β-catenin, DVL-1, and PKCα. (P)RR and PLZF were also measured by RT-PCR. 
Results: We found that offspring developed hypertension. Male descendants remained hypertensive throughout the whole experiment. Female animals tended to recover at second month and returned to normal blood pressure at third month. HRP treatment diminished hypertension in both male and female animals. Morphological evaluations showed changes in heart, aorta, and kidney weight, and HRP reverted this effect. Finally, we found that (P)RR, PLZF, and canonical WNT transduction pathway molecules were stimulated by PE, and HRP treatment abolished this increase. 
Conclusion: These findings suggest that PE can induce hypertension in offspring, and (P)RR seems to play an important role through the canonical WNT pathway and that gender seems to influence this response.


Main Subjects

1. Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: Risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med 2019; 8:1625-1646.
2. Barker DJ. The origins of the developmental origins theory. J Intern Med 2007; 261:412-417.
3. Cheong JN, Wlodek ME, Moritz KM, Cuffe JS. Programming of maternal and offspring disease: Impact of growth restriction, fetal sex and transmission across generations. J Physiol 2016; 594:4727-4740.
4. Paauw ND, van Rijn BB, Lely AT, Joles JA. Pregnancy as a critical window for blood pressure regulation in mother and child: Programming and reprogramming. Acta Physiol (Oxf) 2017; 219:241-259.
5. Vo T, Hardy DB. Molecular mechanisms underlying the fetal programming of adult disease. J Cell Commun Signal 2012; 6:139-153.
6. Ligi I, Grandvuillemin I, Andres V, Dignat-George F, Simeoni U. Low birth weight infants and the developmental programming of hypertension: A focus on vascular factors. Semin Perinatol 2010; 34:188-192.
7. Avila-Ramírez MA, Esteban-Martínez RL, López-Moctezuma E, Anguiano-Robledo L, Hernández-Campos ME, López-Sánchez P. (Pro)renin/renin receptor expression during normal and preeclamptic pregnancy in rats. Life Sci 2019; 216:22-28.
8. Hennrikus M, Gonzalez AA, Prieto MC. The prorenin receptor in the cardiovascular system and beyond. Am J Physiol Heart Circ Physiol 2018; 314:H139-H145.
9. Intapad S, Ojeda NB, Varney E, Royals TP, Alexander BT. Sex-specific effect of endothelin in the blood pressure response to acute angiotensin II in growth-restricted rats. Hypertension 2015; 66:1260-1266.
10. Ichihara A, Hayashi M, Kaneshiro Y, Suzuki F, Nakagawa T, Tada Y, et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of prorenin. J Clin Invest 2004; 114:1128-1135.
11. Ichihara A, Suzuki F, Nakagawa T, Kaneshiro Y, Takemitsu T, Sakoda M, et al. Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 2006; 17:1950-1961.
12. Nguyen G, Muller DN. The biology of the (pro)renin receptor. J Am Soc Nephrol 2010; 21:18-23.
13. Vallee A, Levy BL, Blacher J. Interplay between the renin-angiotensin system, the canonical WNT/beta-catenin pathway and PPARgamma in hypertension. Curr Hypertens Rep 2018; 20:62-74.
14. Badimon L, Borrell-Pages M. Wnt signaling in the vessel wall. Curr Opin Hematol 2017; 24:230-239.
15. Anguiano-Robledo L, Reyes-Melchor PA, Bobadilla-Lugo RA, Perez-Alvarez VM, Lopez-Sanchez P. Renal angiotensin-II receptors expression changes in a model of preeclampsia. Hypertens Pregnancy 2007; 26:151-161.
16. Abitbol MM. Simplified technique to produce toxemia in the rat: considerations on cause of toxemia. Clin Exp Hypertens B 1982; 1:93-103.
17. Podjarny E, Losonczy G, Baylis C. Animal models of preeclampsia. Semin Nephrol 2004; 24:596-606.
18. Li J, LaMarca B, Reckelhoff JF. A model of preeclampsia in rats: The reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol 2012; 303:H1-H8.
19. Javadian P, Salmanian B, Javadi-Paydar M, Shamshirsaz AA, Ejtemaei Mehr S, Gharedaghi MH, et al. Effect of morphine on the reduced uteroplacental perfusion model of pre-eclampsia in rats. Eur J Obstet Gynecol Reprod Biol 2013; 168:161-166.
20. Ramirez-Montero C, Lima-Gomez V, Anguiano-Robledo L, Hernandez-Campos ME, Lopez-Sanchez P. Preeclampsia as predisposing factor for hypertensive retinopathy: Participation by the RAAS and angiogenic factors. Exp Eye Res 2020; 193:107981.
21. Sengupta P. The laboratory rat: Relating its age with human’s. Int J Prev Med 2013; 4:624-630.
22. Sihn G, Rousselle A, Vilianovitch L, Burckle C, Bader M. Physiology of the (pro)renin receptor: Wnt of change? Kidney Int 2010; 78:246-256.
23. Li C, Siragy HM. High glucose induces podocyte injury via enhanced (pro)renin receptor-Wnt-beta-catenin-snail signaling pathway. PLoS One; 9:e89233.
24. Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V. Pregnancy-induced hypertension. Hormones (Athens) 2015; 14:211-223.
25. Sutton EF, Lob HE, Song J, Xia Y, Butler S, Liu CC, et al. Adverse metabolic phenotype of female offspring exposed to preeclampsia in utero: A characterization of the BPH/5 mouse in postnatal life. Am J Physiol Regul Integr Comp Physiol 2017; 312:R485-R491.
26. Calkins K, Devaskar SU. Fetal origins of adult disease. Curr Probl Pediatr Adolesc Health Care 2011; 41:158-176.
27. Ramkumar N, Kohan DE. The (pro)renin receptor: An emerging player in hypertension and metabolic syndrome. Kidney Int 2019; 95:1041-1052.
28. Takimoto-Ohnishi E, Murakami K. Renin-angiotensin system research: From molecules to the whole body. J Physiol Sci 2019; 69:581-587.
29. Miller AJ, Arnold AC. The renin-angiotensin system in cardiovascular autonomic control: Recent developments and clinical implications. Clin Auton Res 2019; 29:231-243.
30. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Nakagawa T, Nishiyama A, et al. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J Am Soc Nephrol 2006; 17:2495-2503.
31. Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M, Suzuki F, Nakagawa T, et al. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension. Hypertension 2006; 47:894-900.
32. Jan Danser AH, Batenburg WW, van Esch JH. Prorenin and the (pro)renin receptor--an update. Nephrol Dial Transplant 2007; 22:1288-1292.
33. Zhao Y, Wang C, Wang C, Hong X, Miao J, Liao Y, et al. An essential role for Wnt/beta-catenin signaling in mediating hypertensive heart disease. Sci Rep 2018; 8:8996-9009.
34. Habas R, Dawid IB. Dishevelled and Wnt signaling: is the nucleus the final frontier? J Biol 2005; 4:2-5.
35. Zhou L, Li Y, Hao S, Zhou D, Tan RJ, Nie J, et al. Multiple genes of the renin-angiotensin system are novel targets of Wnt/beta-catenin signaling. J Am Soc Nephrol 2015; 26:107-120.